166 related articles for article (PubMed ID: 31119054)
1. Clinicopathologic and molecular characteristics of 44 patients with pure secretory breast carcinoma.
Li L; Wu N; Li F; Li L; Wei L; Liu J
Cancer Biol Med; 2019 Feb; 16(1):139-146. PubMed ID: 31119054
[TBL] [Abstract][Full Text] [Related]
2. Secretory breast carcinoma: clinicopathological features and prognosis of 52 patients.
Zhao YY; Ge HJ; Yang WT; Shao ZM; Hao S
Breast Cancer Res Treat; 2024 Feb; 203(3):543-551. PubMed ID: 37897648
[TBL] [Abstract][Full Text] [Related]
3. Secretory Carcinoma of the Breast Mimicking Invasive Ductal Carcinoma: A Case Report.
Kovalenko I; Roy P; Soni B; Sangha L; Toom S
Am J Case Rep; 2022 Aug; 23():e936665. PubMed ID: 35982591
[TBL] [Abstract][Full Text] [Related]
4. Invasive micropapillary carcinoma of the breast: a clinicopathologic study of 103 cases of an unusual and highly aggressive variant of breast carcinoma.
Gokce H; Durak MG; Akin MM; Canda T; Balci P; Ellidokuz H; Demirkan B; Gorken IB; Sevinc AI; Kocdor MA; Saydam S; Harmancioglu O
Breast J; 2013; 19(4):374-81. PubMed ID: 23714006
[TBL] [Abstract][Full Text] [Related]
5. Secretory carcinoma of the breast, commonly exhibits the features of low grade, triple negative breast carcinoma- A Case report with updated review of literature.
Banerjee N; Banerjee D; Choudhary N
Autops Case Rep; 2021; 11():e2020227. PubMed ID: 34277491
[TBL] [Abstract][Full Text] [Related]
6. Secretory carcinoma of the breast: a genetically defined carcinoma entity.
Diallo R; Tognon C; Knezevich SR; Sorensen P; Poremba C
Verh Dtsch Ges Pathol; 2003; 87():193-203. PubMed ID: 16888913
[TBL] [Abstract][Full Text] [Related]
7. Secretory Breast Carcinoma: A Histopathologic and Genomic Spectrum Characterized by a Joint Specific ETV6-NTRK3 Gene Fusion.
Del Castillo M; Chibon F; Arnould L; Croce S; Ribeiro A; Perot G; Hostein I; Geha S; Bozon C; Garnier A; Lae M; Vincent-Salomon A; MacGrogan G
Am J Surg Pathol; 2015 Nov; 39(11):1458-67. PubMed ID: 26291510
[TBL] [Abstract][Full Text] [Related]
8. Concordance of breast cancer biomarker status between routine immunohistochemistry/in situ hybridization and Oncotype DX qRT-PCR with investigation of discordance, a study of 591 cases.
Sechrist H; Glasgow A; Bomeisl P; Gilmore H; Harbhajanka A
Hum Pathol; 2020 Oct; 104():54-65. PubMed ID: 32758491
[TBL] [Abstract][Full Text] [Related]
9. Rare breast cancer: 246 invasive secretory carcinomas from the National Cancer Data Base.
Jacob JD; Hodge C; Franko J; Pezzi CM; Goldman CD; Klimberg VS
J Surg Oncol; 2016 Jun; 113(7):721-5. PubMed ID: 27040042
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological features and genomic profiles of a group of secretory breast carcinomas in which progressive cases have more complex genomic features.
Lei T; Yang Y; Shi Y; Deng X; Peng Y; Wang H; Chen T
Diagn Pathol; 2022 Dec; 17(1):101. PubMed ID: 36585729
[TBL] [Abstract][Full Text] [Related]
11. Correlation of the ultrasound imaging of breast cancer and the expression of molecular biological indexes.
Xu J; Li F; Chang F
Pak J Pharm Sci; 2017 Jul; 30(4(Suppl.)):1425-1430. PubMed ID: 29043992
[TBL] [Abstract][Full Text] [Related]
12. Encapsulated Papillary Carcinoma of Breast: Clinicopathological Features and Prognostic Parameters.
Hashmi AA; Iftikhar SN; Munawar S; Shah A; Irfan M; Ali J
Cureus; 2020 Oct; 12(10):e11282. PubMed ID: 33274157
[TBL] [Abstract][Full Text] [Related]
13. Genomic landscape of secretory carcinoma of the breast with axillary lymph node metastasis.
Chen M; Pu T; Wei B; Bu H; Tang P; Zhang Z
Pathol Res Pract; 2022 Mar; 231():153790. PubMed ID: 35158121
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic characteristics and prognosis of glycogen-rich clear cell carcinoma of the breast.
Ma X; Han Y; Fan Y; Cao X; Wang X
Breast J; 2014; 20(2):166-73. PubMed ID: 24400866
[TBL] [Abstract][Full Text] [Related]
15. Advancement of secretory breast carcinoma: a narrative review.
Min N; Zhu J; Liu M; Li X
Ann Transl Med; 2022 Nov; 10(21):1178. PubMed ID: 36467350
[TBL] [Abstract][Full Text] [Related]
16. The prognostic significance of metaplastic carcinoma of the breast (MCB)--a case controlled comparison study with infiltrating ductal carcinoma.
Lai HW; Tseng LM; Chang TW; Kuo YL; Hsieh CM; Chen ST; Kuo SJ; Su CC; Chen DR
Breast; 2013 Oct; 22(5):968-73. PubMed ID: 23787124
[TBL] [Abstract][Full Text] [Related]
17. The prognoses of metaplastic breast cancer patients compared to those of triple-negative breast cancer patients.
Bae SY; Lee SK; Koo MY; Hur SM; Choi MY; Cho DH; Kim S; Choe JH; Lee JE; Kim JH; Kim JS; Nam SJ; Yang JH
Breast Cancer Res Treat; 2011 Apr; 126(2):471-8. PubMed ID: 21287362
[TBL] [Abstract][Full Text] [Related]
18. Distribution of tumor subtypes in bilateral breast cancer: Comparison between synchronous and metachronous cancer.
Kim H; Lee H; Choi DH; Park W; Cho WK; Nam SJ; Lee JE; Kim SW; Lee SK; Cho EY; Cho SY
Asia Pac J Clin Oncol; 2022 Feb; 18(1):28-34. PubMed ID: 33058534
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic characteristics and prognosis for molecular subtypes in low-grade breast carcinoma: comparison with grade one invasive ductal carcinoma-not otherwise specified.
Wang S; Li W; Liu N; Zhang T; Liu H; Liu J; Liu F; Zhang W; Gebreamlak EP; Niu Y
Med Oncol; 2012 Dec; 29(4):2556-64. PubMed ID: 22311262
[TBL] [Abstract][Full Text] [Related]
20. A case report and literature review on a rare subtype of triple-negative breast cancer in children.
Shi L; Zhang Y; Wu J; Li J; Zhu J; Xu Y; Li N; Li Q; Zhang W
BMC Pediatr; 2023 Sep; 23(1):494. PubMed ID: 37773118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
